KZIA insider transaction filings

KAZIA THERAPEUTICS LTD — 8 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-08. Screen KZIA transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-084Coffey Steven R. S. — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2026-07-084Friend John E. II — Chief Executive OfficerGrant/award (A): 500,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2026-07-084Bonacorda Jeffrey — VP, Finance and ControllerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2026-07-084Davidson Ebru — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2026-07-084Cain David — Director, CMCGrant/award (A): 100,000 (derivative) @ $0EDGAR
2026-07-084APPLE ROBERT F — DirectorGrant/award (A): 75,000 (derivative) @ $0EDGAR
2026-06-234Levine James E. — Chief Financial OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2026-06-234Rao Sudha — Chief Scientific OfficerGrant/award (A): 250,000 (derivative) @ $0EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=KZIA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →